| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9480 |
| Human Intestinal Absorption | HIA+ | 0.9971 |
| Caco-2 Permeability | Caco2+ | 0.8190 |
| P-glycoprotein Substrate | Substrate | 0.7137 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7040 |
| Inhibitor | 0.5999 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5366 |
| Distribution |
| Subcellular localization | Lysosome | 0.4432 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8495 |
| CYP450 2D6 Substrate | Non-substrate | 0.5608 |
| CYP450 3A4 Substrate | Substrate | 0.7251 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9007 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.8950 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8994 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8035 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5827 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9227 |
| Non-inhibitor | 0.9140 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.9372 |
| Fish Toxicity | High FHMT | 0.9364 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8652 |
| Honey Bee Toxicity | Low HBT | 0.5922 |
| Biodegradation | Not ready biodegradable | 0.6580 |
| Acute Oral Toxicity | III | 0.7536 |
| Carcinogenicity (Three-class) | Non-required | 0.5569 |